Mersana Therapeutics Inc (NASDAQ: MRSN) kicked off on Monday, down -6.67% from the previous trading day, before settling in for the closing price of $0.75. Over the past 52 weeks, MRSN has traded in a range of $0.49-$6.28.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 15390.52% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded 58.87%. With a float of $86.42 million, this company’s outstanding shares have now reached $122.87 million.
In an organization with 123 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 48.0%, operating margin of -228.07%, and the pretax margin is -212.99%.
Mersana Therapeutics Inc (MRSN) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Mersana Therapeutics Inc is 30.04%, while institutional ownership is 60.33%. The most recent insider transaction that took place on Jan 16 ’25, was worth 2,061. In this transaction VP, Chief Accounting Officer of this company sold 3,554 shares at a rate of $0.58, taking the stock ownership to the 57,519 shares. Before that another transaction happened on Jan 16 ’25, when Company’s Director sold 8,637 for $0.58, making the entire transaction worth $5,009. This insider now owns 168,041 shares in total.
Mersana Therapeutics Inc (MRSN) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.17 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 58.87% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 20.92% during the next five years compared to 11.93% growth over the previous five years of trading.
Mersana Therapeutics Inc (NASDAQ: MRSN) Trading Performance Indicators
Take a look at Mersana Therapeutics Inc’s (MRSN) current performance indicators. Last quarter, stock had a quick ratio of 2.35. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.48.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.61, a number that is poised to hit -0.16 in the next quarter and is forecasted to reach -0.69 in one year’s time.
Technical Analysis of Mersana Therapeutics Inc (MRSN)
Let’s dig in a bit further. During the last 5-days, its volume was 7.24 million. That was inferior than the volume of 8.88 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 59.29%. Additionally, its Average True Range was 0.12.
During the past 100 days, Mersana Therapeutics Inc’s (MRSN) raw stochastic average was set at 8.92%, which indicates a significant decrease from 63.92% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 149.53% in the past 14 days, which was higher than the 144.30% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.3731, while its 200-day Moving Average is $1.9121. However, in the short run, Mersana Therapeutics Inc’s stock first resistance to watch stands at $0.7415. Second resistance stands at $0.7831. The third major resistance level sits at $0.8038. If the price goes on to break the first support level at $0.6792, it is likely to go to the next support level at $0.6585. Assuming the price breaks the second support level, the third support level stands at $0.6169.
Mersana Therapeutics Inc (NASDAQ: MRSN) Key Stats
The company with the Market Capitalisation of 86.47 million has total of 123,533K Shares Outstanding. Its annual sales at the moment are 36,860 K in contrast with the sum of -171,670 K annual income. Company’s last quarter sales were recorded 12,600 K and last quarter income was -11,500 K.
